Discover how HYS-072, a novel chrysin derivative, effectively combats triple-negative breast cancer through apoptosis and autophagy induction.
Exploring how prenylated stilbenoids enhance paclitaxel efficacy in triple-negative breast cancer treatment through synergistic mechanisms and natural compounds.